Ann Dermatol.  2012 Nov;24(4):491-493. 10.5021/ad.2012.24.4.491.

Tripartite Motif-Containing 29 Expression in Squamous Cell Carcinoma

• Cho MK

• KMID: 2266056
• DOI: http://doi.org/10.5021/ad.2012.24.4.491

Abstract

No abstract available.

MeSH Terms

Carcinoma, Squamous Cell

Figure

• 

  Fig. 1 (A) TRIM29 protein was expressed on squamous cell carcinomal, normal skin tissue by western blot analysis. (B) The score of relative TRIM29 expression amount in western blotting. TRIM29: tripartite motif-containing 29, MM: malignant melanoma, SCC: squamous cell carcinoma, BCC: basal cell carcinoma.

• 

  Fig. 2 Immunohistochemical analysis of tripartite motif-containing 29 (TRIM29) expression in (A) malignant melanoma, (B) squamous cell carcinoma, (C) basal cell carcinoma, and (D) normal skin tissue. Only squamous cell carcinoma displayed TRIM29 expression. (A, B, C: ×200, D: ×100).

Reference

1. Quaderi NA, Schweiger S, Gaudenz K, Franco B, Rugarli EI, Berger W, et al. Opitz G/BBB syndrome, a defect of midline development, is due to mutations in a new RING finger gene on Xp22. Nat Genet. 1997. 17:285–291.

2. Reymond A, Meroni G, Fantozzi A, Merla G, Cairo S, Luzi L, et al. The tripartite motif family identifies cell compartments. EMBO J. 2001. 20:2140–2151.

3. Hosoi Y, Kapp LN. Expression of a candidate ataxia-telangiectasia group D gene in cultured fibroblast cell lines and human tissues. Int J Radiat Biol. 1994. 66:6 Suppl. S71–S76.

4. Ernst T, Hergenhahn M, Kenzelmann M, Cohen CD, Bonrouhi M, Weninger A, et al. Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma: a gene expression analysis on total and microdissected prostate tissue. Am J Pathol. 2002. 160:2169–2180.

5. Nacht M, Ferguson AT, Zhang W, Petroziello JM, Cook BP, Gao YH, et al. Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer. Cancer Res. 1999. 59:5464–5470.

6. Liu J, Welm B, Boucher KM, Ebbert MT, Bernard PS. TRIM29 functions as a tumor suppressor in nontumorigenic breast cells and invasive ER+ breast cancer. Am J Pathol. 2012. 180:839–847.

7. Schlomm T, Luebke AM, Sültmann H, Hellwinkel OJ, Sauer U, Poustka A, et al. Extraction and processing of high quality RNA from impalpable and macroscopically invisible prostate cancer for microarray gene expression analysis. Int J Oncol. 2005. 27:713–720.

8. Kosaka Y, Inoue H, Ohmachi T, Yokoe T, Matsumoto T, Mimori K, et al. Tripartite motif-containing 29 (TRIM29) is a novel marker for lymph node metastasis in gastric cancer. Ann Surg Oncol. 2007. 14:2543–2549.